Stock Doctor Ltd SC804107 false 2024-03-22 2025-04-30 2025-04-30 The principal activity of the company is Investment consultant Digita Accounts Production Advanced 6.30.9574.0 true SC804107 2024-03-22 2025-04-30 SC804107 2025-04-30 SC804107 core:CurrentFinancialInstruments 2025-04-30 SC804107 core:CurrentFinancialInstruments core:WithinOneYear 2025-04-30 SC804107 bus:SmallEntities 2024-03-22 2025-04-30 SC804107 bus:AuditExemptWithAccountantsReport 2024-03-22 2025-04-30 SC804107 bus:FilletedAccounts 2024-03-22 2025-04-30 SC804107 bus:SmallCompaniesRegimeForAccounts 2024-03-22 2025-04-30 SC804107 bus:RegisteredOffice 2024-03-22 2025-04-30 SC804107 bus:Director2 2024-03-22 2025-04-30 SC804107 bus:OrdinaryShareClass1 2024-03-22 2025-04-30 SC804107 bus:PrivateLimitedCompanyLtd 2024-03-22 2025-04-30 SC804107 countries:Scotland 2024-03-22 2025-04-30 iso4217:GBP xbrli:pure

Registration number: SC804107

Stock Doctor Ltd

Unaudited Financial Statements

for the Period from 22 March 2024 to 30 April 2025

 

Stock Doctor Ltd

Contents

Statement of Financial Position

1

Notes to the Unaudited Financial Statements

2 to 4

 

Stock Doctor Ltd

(Registration number: SC804107)
Statement of Financial Position as at 30 April 2025

Note

2025
£

Current assets

 

Debtors

4

6,688

Creditors: Amounts falling due within one year

5

(3,687)

Net assets

 

3,001

Capital and reserves

 

Called up share capital

1

Retained earnings

3,000

Shareholders' funds

 

3,001

For the financial period ending 30 April 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the Company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the Directors have not delivered to the registrar a copy of the Income Statement.

Approved and authorised by the Board on 17 June 2025 and signed on its behalf by:
 

.........................................
Vladimir Zabnin
Director

 

Stock Doctor Ltd

Notes to the Unaudited Financial Statements for the Period from 22 March 2024 to 30 April 2025

1

General information

The Company is a private company limited by share capital, incorporated in Scotland.

The address of its registered office is:
29 Commercial Street
Dundee
Tayside
DD1 3DG
Scotland

These financial statements were authorised for issue by the Board on 17 June 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the Company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The Company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the Company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates taxable income.

 

Stock Doctor Ltd

Notes to the Unaudited Financial Statements for the Period from 22 March 2024 to 30 April 2025

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Dividends

Dividend distribution to the Company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Financial instruments

Classification
Financial instruments are classified and accounted for, according to the substance of the contractual agreement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
 

3

Staff numbers

The average number of persons employed by the Company (including Directors) during the period, was 2.

4

Debtors

Current

2025
£

Other debtors

6,688

 

6,688

 

Stock Doctor Ltd

Notes to the Unaudited Financial Statements for the Period from 22 March 2024 to 30 April 2025

5

Creditors

Creditors: amounts falling due within one year

2025
£

Due within one year

Taxation and social security

3,687

6

Dividends

Interim dividends paid

2025
£

Interim dividend of £140.73 per each Ordinary A

12,666